Verus Capital Partners LLC Acquires New Stake in Kenvue Inc. $KVUE

Verus Capital Partners LLC bought a new position in shares of Kenvue Inc. (NYSE:KVUE) during the 3rd quarter, HoldingsChannel.com reports. The institutional investor bought 27,150 shares of the company’s stock, valued at approximately $441,000.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Salomon & Ludwin LLC bought a new position in Kenvue during the third quarter valued at about $25,000. NBT Bank N A NY grew its stake in shares of Kenvue by 180.3% in the 3rd quarter. NBT Bank N A NY now owns 1,564 shares of the company’s stock worth $25,000 after purchasing an additional 1,006 shares during the last quarter. Cornerstone Planning Group LLC raised its holdings in shares of Kenvue by 705.2% in the 3rd quarter. Cornerstone Planning Group LLC now owns 1,554 shares of the company’s stock worth $25,000 after purchasing an additional 1,361 shares in the last quarter. Golden State Wealth Management LLC lifted its stake in Kenvue by 150.1% during the third quarter. Golden State Wealth Management LLC now owns 1,983 shares of the company’s stock valued at $32,000 after purchasing an additional 1,190 shares during the last quarter. Finally, Trust Co. of Vermont boosted its holdings in Kenvue by 50.9% during the third quarter. Trust Co. of Vermont now owns 2,385 shares of the company’s stock worth $39,000 after buying an additional 804 shares in the last quarter. Institutional investors own 97.64% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have recently commented on KVUE shares. Zacks Research upgraded Kenvue from a “strong sell” rating to a “hold” rating in a research report on Wednesday, November 26th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Kenvue in a research report on Friday, January 9th. Johnson Rice restated a “neutral” rating on shares of Kenvue in a report on Tuesday, October 28th. Evercore set a $18.00 target price on shares of Kenvue in a report on Tuesday, October 28th. Finally, Canaccord Genuity Group boosted their target price on shares of Kenvue from $17.00 to $18.00 and gave the company a “hold” rating in a research note on Wednesday, February 18th. Three equities research analysts have rated the stock with a Buy rating and twelve have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $19.50.

Kenvue Trading Up 0.4%

NYSE:KVUE opened at $19.02 on Wednesday. The company has a market capitalization of $36.46 billion, a P/E ratio of 24.71, a P/E/G ratio of 4.34 and a beta of 0.59. The stock’s 50 day moving average price is $17.61 and its 200 day moving average price is $17.55. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.69 and a current ratio of 0.96. Kenvue Inc. has a 52 week low of $14.02 and a 52 week high of $25.17.

Kenvue (NYSE:KVUE) last issued its quarterly earnings data on Tuesday, February 17th. The company reported $0.27 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.22 by $0.05. The firm had revenue of $3.78 billion during the quarter, compared to analysts’ expectations of $3.68 billion. Kenvue had a net margin of 9.72% and a return on equity of 19.72%. Kenvue’s revenue for the quarter was up 3.2% on a year-over-year basis. During the same period in the prior year, the company posted $0.26 earnings per share. On average, research analysts forecast that Kenvue Inc. will post 1.14 EPS for the current fiscal year.

Kenvue Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, February 25th. Investors of record on Wednesday, February 11th will be issued a $0.2075 dividend. This represents a $0.83 annualized dividend and a yield of 4.4%. The ex-dividend date is Wednesday, February 11th. Kenvue’s dividend payout ratio (DPR) is 107.79%.

Insider Transactions at Kenvue

In other Kenvue news, Director Jeffrey C. Smith purchased 3,200,000 shares of the stock in a transaction dated Friday, December 12th. The shares were bought at an average cost of $17.37 per share, with a total value of $55,584,000.00. Following the completion of the transaction, the director owned 27,307,632 shares in the company, valued at $474,333,567.84. This trade represents a 13.27% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.17% of the stock is owned by company insiders.

About Kenvue

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.